These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3015694)

  • 21. Serum androstanediol glucuronide in women with facial hirsutism.
    Salman K; Spielvogel RL; Shulman LH; Miller JL; Vanderlinde RE; Rose LI
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin modulates peripheral androgen metabolism.
    Serafini P; Lobo RA
    Fertil Steril; 1986 Jan; 45(1):41-6. PubMed ID: 2935426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction.
    Scanlon MJ; Whorwood CB; Franks S; Reed MJ; James VH
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):529-38. PubMed ID: 3253032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
    Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
    Brochu M; Bélanger A; Tremblay RR
    Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased 5 alpha-reductase activity in idiopathic hirsutism.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Jan; 43(1):74-8. PubMed ID: 3155511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of the effects of dexamethasone administration on urinary 17-ketosteroid and serum androgen levels in patients with hirsutism.
    Judd HL; McPherson RA; Rakoff JS; Yen SS
    Am J Obstet Gynecol; 1977 Jun; 128(4):408-17. PubMed ID: 141210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The corticotrophin releasing factor test: a valuable and rapid procedure for the differential diagnosis of hirsutism.
    Georgala S; Schulpis K; Tolis G
    J Int Med Res; 1992 Feb; 20(1):40-4. PubMed ID: 1314743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence of non-classical 21-hydroxylase deficiency in hirsute adolescent girls.
    Akinci A; Yordam N; Ersoy F; Uluşahin N; Oğuz H
    Gynecol Endocrinol; 1992 Jun; 6(2):99-106. PubMed ID: 1323921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF; Finegold DN; Lanes R; Lee PA
    N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurements of 3 alpha,17 beta-androstanediol glucuronide in serum and urine and the correlation with skin 5 alpha-reductase activity.
    Paulson RJ; Serafini PC; Catalino JA; Lobo RA
    Fertil Steril; 1986 Aug; 46(2):222-6. PubMed ID: 3732528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of clinical and hormonal effects in hirsute women treated with ketoconazole.
    Conget JI; Halperin I; Ferrer J; González-Clemente JM; Martinez-Osaba MJ; Vilardell E
    J Endocrinol Invest; 1990 Dec; 13(11):867-70. PubMed ID: 2151039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of basal hormone levels in hirsute women.
    Bohnet HG; Kato K
    Exp Clin Endocrinol; 1987 Mar; 89(1):31-8. PubMed ID: 2954834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
    Thompson DL; Horton N; Rittmaster RS
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):283-92. PubMed ID: 2160872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Female androgenic alopecia. The 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness.
    De Villez RL; Dunn J
    Arch Dermatol; 1986 Sep; 122(9):1011-5. PubMed ID: 2943232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
    Vogt C; Dericks-Tan JS; Kuhl H; Taubert HD
    Gynecol Endocrinol; 1992 Jun; 6(2):85-90. PubMed ID: 1386956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dexamethasone and clomiphene citrate on peripheral steroid levels and ovarian function in a hirsute amenorrheic patient.
    Chang RJ; Abraham GE
    Fertil Steril; 1976 Jun; 27(6):640-6. PubMed ID: 132375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral, ovarian, and adrenal vein steroids in hirsute women: acute effects of human chorionic gonadotropin and adrenocorticotrophic hormone.
    Parker CR; Bruneteau DW; Greenblatt RB; Mahesh VB
    Fertil Steril; 1975 Sep; 26(9):877-88. PubMed ID: 126875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.